Skip to main content
Caplight Logo









GenoPalate, Inc.

GenoPalate, Inc.

Private
Milwaukee, WisconsinHealthcare & Life Scienceshttps://www.genopalate.com/

Last Round

Seed Round

Mar 4, 2026

Total Funding Raised

$14.09M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

GenoPalate, Inc. is a nutritional genomics company that provides personalized nutrition and supplement recommendations based on DNA analysis, blood biomarkers, and lifestyle data.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

personalized nutritiongenetic testingDTCDNA nutrition kitdirect-to-consumernutrigenomicsdietary recommendationsprecision medicinemeal plannerbiohackingDNA diethealth coachingsubscription SaaSwellness tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GenoPalate, Inc. Comparables

Compare GenoPalate, Inc. with similar companies based on industry and business-model similarity.

GenoPalate, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Silverberry Genomix
84%
Genomelink
82%
Rootine
82%

GenoPalate, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMar 4, 2026
Series A ExtensionOct 25, 2022
Series ADec 29, 2020
SeedDec 3, 2018
SeedMar 29, 2018
Accelerator
May 15, 2017

Key People

Founding team and executive leadership

Asif Naseem

Chief Executive Officer

Executive Team

GenoPalate, Inc. Investors

Notable investors and investment history

GenoPalate, Inc. investors
InvestorRounds
gener8torSeed, Accelerator, Series B
BrightStar Wisconsin FoundationSeed, Series B
gBETASeed, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 44% MoM.

  • Jul 13, 2026

    Open roles increased to 8, 62% of headcount.

GenoPalate, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GenoPalate, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GenoPalate, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMilwaukee, Wisconsin
Employee Range13
Year Founded2016
Last FundingMar 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?